Cardiology Product Guide » atrial fibrillation

CorMatrix Receives FDA IDE Approval To Begin Prospective, Randomized Evaluation Of New Onset Postoperative Atrial Fibrillation

admin — Mon, 13 Sep 2010 05:01:01 +0000

CorMatrix Cardiovascular, Inc. announced that FDA has granted conditional approval for the start of a multi-center, randomized clinical trial to demonstrate the safety of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation. Patients enrolled in the trial will undergo circumferential reconstruction of the normal pericardial anatomy following isolated, first-time, coronary artery bypass grafting (CABG) procedures and will be compared to subjects who do not undergo pericardial closure.

Read the full story here

NICE Publishes Final Draft Guidance On The Use Of Dronedarone For Treating Atrial Fibrillation

admin — Mon, 19 Jul 2010 08:56:00 +0000

The National Institute for Health and Clinical Excellence (NICE) is currently appraising the use of dronedarone (Multaq) for the treatment of atrial fibrillation (AF) – a disturbance of the heart’s rhythm. In its final draft guidance, NICE has reaffirmed the decision in its previous draft to recommend the limited use of the drug as a second-line treatment in people with additional cardiovascular risk factors whose AF has not been controlled by first-line therapy.

Read the full story here

Use Polysomnography To Diagnose Obstructive Sleep Apnea: Research

admin — Wed, 14 Jul 2010 19:33:29 +0000

Obstructive sleep apnea is a frequent comorbidity in patients suffering from atrial fibrillation, and polysomnography should be used to diagnose it. According to a research presented at SLEEP 2010: Associated Professional Sleep Societies 24th Annual Meeting, portable diagnostic methods underestimate the incidence of obstructive sleep apnea in these patients.
Read the full story here.

New Algorithm Can Detect Atrial Fibrillation with 95% Accuracy

admin — Mon, 24 May 2010 14:57:34 +0000

A new algorithm can now detect atrial fibrillation with a 95 accuracy. This is a huge improvement over previous methods. Atrial fibrillation, which affects about three million Americans, is an independent risk factor for death and a major cause of ischemic stroke, in which blood flow is reduced to part of the brain. Atrial Fibrillation can be treated, but it is notoriously difficult to detect. The new algorithm was developed by Ki H. Chon, PhD, head of the Department of Biomedical Engineering at Worcester Polytechnic Institute (WPI), in partnership with Snehraj Merchant of The ScottCare Corporation.

To read the full article, click here.